Dr. John Heinzerling presents findings with Stereotactic Ablative Radiation Therapy (SBRT) for early stage lung cancer

Written By: Dr. John Heinzerling

Dr. John Heinzerling from SERO presents findings on a large institutional experience with stereotactic ablative radiation therapy (SBRT) for early stage lung cancer at this year’s annual ASTRO meeting. This large experience suggested results and outcomes that were comparable to previous national trials showing the expertise of SERO in the delivery of this highly technical, advanced therapy.